Skip to main content
Log in

High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis

  • Letters to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007;42:573–582.

    Article  PubMed  CAS  Google Scholar 

  2. Kim JY, Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621–2637.

    Article  PubMed  CAS  Google Scholar 

  3. Bains RK, Wells SE, Flavell DM, Fairhall KM, Strom M, Tissier PL, et al. Visceral obesity without insulin resistance in late-onset obesity rats. Endocrinology 2004;145:2666–2679.

    Article  PubMed  CAS  Google Scholar 

  4. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347–2355.

    Article  PubMed  CAS  Google Scholar 

  5. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494–1505.

    Article  PubMed  CAS  Google Scholar 

  6. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007;85:1197–1202.

    PubMed  CAS  Google Scholar 

  7. Oda E, Abe M, Veeraveedu PT, Watanabe K. Considerable disagreements among definitions of metabolic syndrome for Japanese. Circ J 2007;71:1239–1243.

    Article  PubMed  Google Scholar 

  8. Oda E, Oohara K, Abe A, Veeraveedu PT, Watanabe K, Kato K, et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Circ J 2006;70:384–388.

    Article  PubMed  CAS  Google Scholar 

  9. Matsushita K, Yatsuya H, Tamakoshi K, Yang PO, Otsuka R, Wada K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007;71:820–825.

    Article  PubMed  CAS  Google Scholar 

  10. Oda E. The CRP cut-point of 0.65 mg/L may be appropriate not only as a component of metabolic syndrome but also as a risk predictor of cardiovascular disease (letter). Circ J 2007;71:1501.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oda, E., Watanabe, K. High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis. J Gastroenterol 43, 312–313 (2008). https://doi.org/10.1007/s00535-008-2175-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2175-8

Keywords

Navigation